Analyst Recommendations

Leerink Partners analyst issues OUTPERFORM recommendation for ROIV on October 21, 2024 05:58AM ET. The previous analyst recommendation was Outperform.ROIV was trading at $11.92 at issue of the...

October 21, 2024   ROIV 5.87%

Citigroup analyst issues BUY recommendation for YLLXF on October 21, 2024 01:38AM ET. YLLXF was trading at $7.795 at issue of the analyst recommendation.The overall analyst consensus :...

October 21, 2024   YLLXF 1.35%

Morgan Stanley analyst issues OVERWEIGHT recommendation for BIOA on October 21, 2024 01:37AM ET. BIOA was trading at $23.86 at issue of the analyst recommendation.The overall analyst consensus...

October 21, 2024   BIOA 2.69%

Citigroup analyst issues REDUCE recommendation for PPRUY on October 21, 2024 01:38AM ET. PPRUY was trading at $25.8 at issue of the analyst recommendation.The overall analyst consensus :...

October 21, 2024   PPRUY 0.85%

Bernstein analyst issues OUTPERFORM recommendation for NA on October 21, 2024 03:02AM ET. The previous analyst recommendation was Outperform.NA was trading at $0.6235 at issue of the analyst...

October 21, 2024   NA 3.73%

Jefferies analyst issues BUY recommendation for SRPT on October 21, 2024 03:36AM ET. SRPT was trading at $127.08 at issue of the analyst recommendation.The overall analyst consensus :...

October 21, 2024   SRPT 1.54%

Jefferies analyst issues HOLD recommendation for SW on October 21, 2024 03:35AM ET. The previous analyst recommendation was Buy.SW was trading at $44.35 at issue of the analyst...

October 21, 2024   SW 0.17%

Jefferies analyst issues BUY recommendation for BIOA on October 21, 2024 03:37AM ET. BIOA was trading at $23.86 at issue of the analyst recommendation.The overall analyst consensus :...

October 21, 2024   BIOA 2.69%

Piper Sandler analyst issues OVERWEIGHT recommendation for CAPR on October 21, 2024 03:40AM ET. CAPR was trading at $18.86 at issue of the analyst recommendation.The overall analyst consensus...

October 21, 2024   CAPR -1.08%

Jefferies analyst issues BUY recommendation for BKV on October 21, 2024 03:39AM ET. BKV was trading at $18.45 at issue of the analyst recommendation.The overall analyst consensus :...

October 21, 2024   BKV 0.51%